» Articles » PMID: 22658336

Regioselective N1-alkylation of 3,4-dihydropyrimidine-2(1H)-ones: Screening of Their Biological Activities Against Ca(2+)-ATPase

Overview
Journal Eur J Med Chem
Specialty Chemistry
Date 2012 Jun 5
PMID 22658336
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A regioselective N1-alkylation of 3,4-dihydropyrimidin-2(1H)-ones using a very efficient mild base Cs(2)CO(3) and alkyl halides at room temperature has been reported. The selectivity of this methodology is excellent and the yields of the alkylated products are very good. Furthermore inhibitory action of both the 3,4-dihydropyrimidin-2(1H)-ones and the N1-alkylated derivatives were tested on Ca(2+)-ATPase, which revealed that the parent compounds can act as Ca(2+)-ATPase inhibitors whereas the N1-alkylated derivatives are inefficient for this purpose.

Citing Articles

Synthesis, Characterization, and Anticancer Activities Evaluation of Compounds Derived from 3,4-Dihydropyrimidin-2(1)-one.

Liu Y, Liu J, Zhang R, Guo Y, Wang H, Meng Q Molecules. 2019; 24(5).

PMID: 30832453 PMC: 6429579. DOI: 10.3390/molecules24050891.


Effect of N-1 arylation of monastrol on kinesin Eg5 inhibition in glioma cell lines.

Goncalves I, Rockenbach L, das Neves G, Goethel G, Nascimento F, Kagami L Medchemcomm. 2018; 9(6):995-1010.

PMID: 30108989 PMC: 6072436. DOI: 10.1039/c8md00095f.